diagnostic assaysAstra Biotech GmbH, Berlin, Germany is inviting new customers to evaluate their comprehensive range of diagnostic assays as a test of their quality and value for money. The concept is that customers may trial a specific test kit to ensure it is suitable for their application before adopting the test on a more formal basis.  All that is required is feedback at the end of the trial to help understand how the assays performed during the evaluation.

To complement the existing range of products Astra Biotech GmbH are continuing to develop diagnostic assays for the prevention of disease and to identify any individual predisposition to possible major illness while trying to reduce the cost per analysis which is a significant factor in today's laboratories. 

Cost may be a factor however Astra Biotech GmbH will never compromise quality as demonstrated by the fact that they only use traceable reagents in production. All the assays are IVD compliant and come with comprehensive instructions so that they are easy to incorporate into the daily routine.

For laboratories who are concerned about their running costs or are using "research only" assays, then the Astra Biotech GmbH evaluation program is the ideal, no risk option so why not JUST DO IT?

For further information please visit www.astrabiotech.de

If you have not logged into the website then please enter your details below.


Popular this Month


Chromatography in Cannabis Testing


New Catalogue of Infectious Disease Antibodies and Antigens


Acquisition of B&W Tek takes Metrohm’s Spectroscopy Portfolio to the Next Level


Gilson announce the release of the extended mass range VERITY® 1910 MS Detector


NanoFCM Opens European Office and Centre of Excellence for Scientific Application Support


Hitachi High-Technologies Launches Two New Scanning Electron Microscopes


Discovery Park & MedCity to Partner on Prestigious Angels In MedCity Programme


Merck Lectureship 2019 Awarded to Susumu Kitagawa


BioCity Invests in Carbon Recycling Start-Up, Deep Branch Biotechnology


Agilent Announces Unique Portfolio to Advance Immunotherapy






Can't find what you are looking for?

Search by company or by product

Company Name:




Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd


Previous | Next